| missense mutation | Q2656896 |
| P3329 | CIViC variant ID | 148 |
| P6861 | dbSNP Reference SNP number | rs121913529 |
| P3331 | HGVS nomenclature | ENST00000256078.4:c.35G>C |
| NC_000012.11:g.25398284C>G | ||
| NM_004985.4:c.35G>C | ||
| NP_004976.2:p.Gly12Ala |
| P3433 | biological variant of | KRAS | Q20969980 |
| P1057 | chromosome | human chromosome 12 | Q847102 |
| P645 | genomic end | 25398284 | |
| P644 | genomic start | 25398284 | |
| P3355 | negative therapeutic predictor for | regorafenib | Q3891664 |
| panitumumab | Q417775 | ||
| gefitinib | Q417824 | ||
| erlotinib | Q418369 | ||
| cetuximab | Q420296 | ||
| melphalan | Q2298283 |